Factors Influencing Adherence in Cancer Patients Taking Oral Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors Influencing Adherence in Cancer Patients Taking Oral Tyrosine Kinase Inhibitors

Published:2016-03 Issue:2 Volume:39 Page:153-162
ISSN:0162-220X
Container-title:Cancer Nursing
language:en
Short-container-title:

Author:

Verbrugghe Mathieu,Duprez Veerle,Beeckman Dimitri,Grypdonck Mieke,Quaghebeur Marijke,Verschueren Caroline,Verhaeghe Sofie,Van Hecke Ann

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology(nursing),Oncology

Reference48 articles.

1. Anticancer oral therapy: emerging related issues.;Banna;Cancer Treat Rev,2010

2. Role of tyrosine kinase inhibitors in cancer therapy.;Arora;Perspect Pharmacol,2005

3. Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance.;Levitzki;Annu Rev Pharmacol Toxicol,2013

4. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.;Noens;Blood,2009

5. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.;Marin;J Clin Oncol,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient reported medication-related problems, adherence and waste of oral anticancer medication over time;European Journal of Hospital Pharmacy;2024-07-17

2. Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study;BMJ Open;2024-02

3. A Qualitative Exploration of Medication Experience and Factors Contributing to Adherence to Oral-Targeted Therapy Among Lung Cancer Survivors;Seminars in Oncology Nursing;2022-12

4. Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study;2022-09-15

5. A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions;Journal of Oncology Pharmacy Practice;2022-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3